• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimadazole-4-carboxamide
Date Designated: 12/18/2007
Orphan Designation: Treatment of malignant melanoma stages IIb through IV.
Orphan Designation Status: Designated/Withdrawn
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
AbbVie, Inc.
1 N. Waukegan Road
North Chicago, Illinois 60064
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-